{
    "id": 1173,
    "fullName": "NRAS Q61X",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "NRAS Q61X indicates any NRAS missense mutation that results in replacement of the glutamine (Q) at amino acid 61 by a different amino acid. NRAS codon 61 mutations are hotspot mutations that often result in a loss of Nras GTPase activity and activation of downstream pathways (PMID: 27664710, PMID: 28666118, PMID: 22589270, PMID: 26985062).",
            "references": [
                {
                    "id": 9838,
                    "pubMedId": 27664710,
                    "title": "NRAS, NRAS, Which Mutation Is Fairest of Them All?",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27664710"
                },
                {
                    "id": 12404,
                    "pubMedId": 26985062,
                    "title": "RAS isoforms and mutations in cancer at a glance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26985062"
                },
                {
                    "id": 9843,
                    "pubMedId": 28666118,
                    "title": "RAS Proteins and Their Regulators in Human Disease.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28666118"
                },
                {
                    "id": 2097,
                    "pubMedId": 22589270,
                    "title": "A comprehensive survey of Ras mutations in cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22589270"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 4893,
        "geneSymbol": "NRAS",
        "terms": [
            "NRAS",
            "ALPS4",
            "CMNS",
            "N-ras",
            "NCMS",
            "NRAS1",
            "NS6"
        ]
    },
    "variant": "Q61X",
    "createDate": "07/27/2014",
    "updateDate": "11/12/2019",
    "referenceTranscriptCoordinates": {
        "id": 162463,
        "transcript": "NM_002524",
        "gDna": "chr1:g.114713907_114713909",
        "cDna": "c.181_183",
        "protein": "p.Q61",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17121,
            "approvalStatus": "FDA contraindicated",
            "evidenceType": "Actionable",
            "efficacyEvidence": "Vectibix (panitumumab) treatment of colorectal cancer patients with NRAS exon 3, codon 61 mutations is contraindicated (FDA.gov).",
            "molecularProfile": {
                "id": 1198,
                "profileName": "NRAS Q61X"
            },
            "therapy": {
                "id": 845,
                "therapyName": "Panitumumab",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15480,
                    "pubMedId": null,
                    "title": "Vectibix (panitumumab) FDA Drug Label",
                    "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 13670,
            "approvalStatus": "Guideline",
            "evidenceType": "Prognostic",
            "efficacyEvidence": "NRAS Q61X is associated with a poor prognosis in patients with myelodysplastic syndrome (NCCN.org).",
            "molecularProfile": {
                "id": 1198,
                "profileName": "NRAS Q61X"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 50908,
                "name": "myelodysplastic syndrome",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 17107,
            "approvalStatus": "FDA contraindicated",
            "evidenceType": "Actionable",
            "efficacyEvidence": "Erbitux (cetuximab) treatment of colorectal cancer patients with NRAS exon 3, codon 61 mutations is contraindicated (FDA.gov).",
            "molecularProfile": {
                "id": 1198,
                "profileName": "NRAS Q61X"
            },
            "therapy": {
                "id": 694,
                "therapyName": "Cetuximab",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15479,
                    "pubMedId": null,
                    "title": "Erbitux (cetuximab) FDA Drug Label",
                    "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125084"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1198,
            "profileName": "NRAS Q61X",
            "profileTreatmentApproaches": [
                {
                    "id": 16390,
                    "name": "MEK1 Inhibitor",
                    "profileName": "NRAS Q61X"
                },
                {
                    "id": 16386,
                    "name": "MEK2 Inhibitor",
                    "profileName": "NRAS Q61X"
                },
                {
                    "id": 16387,
                    "name": "PIK3CA inhibitor",
                    "profileName": "NRAS Q61X"
                },
                {
                    "id": 16389,
                    "name": "RAS Inhibitor (Pan)",
                    "profileName": "NRAS Q61X"
                },
                {
                    "id": 16388,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "NRAS Q61X"
                },
                {
                    "id": 16385,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "NRAS Q61X"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 162463,
            "transcript": "NM_002524",
            "gDna": "chr1:g.114713907_114713909",
            "cDna": "c.181_183",
            "protein": "p.Q61",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}